Clinical trial
A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of the NOVA Sirolimus Eluting Stent Versus the Apollo Stent
NCT02578069 is registered in ClinicalTrials.gov with Sino Medical Sciences Technology Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of the NOVA Sirolimus Eluting Stent Versus the Apollo Stent
- Lead sponsor
- Sino Medical Sciences Technology Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2015
- Completion date
- January 31, 2020
- Enrollment
- 272 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.